Accepted at 5:47 a.m. Jun, 29, 2025 by Jwill
Author: andrewmathias8
Related Note: 1477432914191
Rationale for change

Proper terminology

https://next.amboss.com/us/article/8N0O1g?utm_source=navbar&utm_medium=anki&utm_campaign=anki&utm_term=%25CE%25B1%2Bmethyldopa&guid=c6KXj%2526iT57&aid=298bfc66-b119-4c76-b7ef-8bfc7d192ab2&uid=ptfeLeLy0#Z8a14b4a74432cd1c865fe99c3e7cf55c

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Other::Only_Step_1 #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Cardiology::Hypertension #AK_Step1_v12::#Physeo::09_Pharm::16_Autonomic_Pharm::03_Alpha_agonists #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::14_alpha-blockers #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::13_Sympatholytics_(alpha2-agonists)::*Sympatholytics_(a2-Agonists)::a2_Agonists::a-Methyldopa #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::09_Antihypertensive_Drugs #AK_Step2_v12::#SketchyIM::07_Rheumatology::07_Systemic_Diseases::02_Systemic_Lupus_Erythematosus_SOAP #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::14_Sympatholytics #AK_Step1_v12::#Pixorize::03_Pharmacology::23_Sympathomimetics_&_Sympatholytics_(New)::04_Alpha_Methyldopa #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::03_Alpha_drugs #AK_Step1_v12::#Bootcamp::Musculoskeletal::03_Rheumatologic_Disease::02_Systemic_Lupus_Erythematosus